Who is eligible for the first FDA-approved RSV vaccine? Find out about this and more in today's PV Roundup podcast.

Dr. Holly Lofton, a medical weight management specialist joins me to discuss on-label and off-label uses of GLP-1 agonists including Ozempic in this edition of the PV Roundup specialist spotlight.

Does long COVID have lasting effects on brain activity? Find out about this and more in today's PV Roundup podcast.

Angela R. Branche, MD, FIDSA, and Laura P. Hurley, MD, MPH, discuss research on PCPs' perceptions of RSV disease burden; current RSV testing practices; and potential barriers to adoption of any RSV vaccine.

Can a personalized cancer vaccine extend survival in patients with melanoma? Find out about this and more in today's PV Roundup podcast.

Angela R. Branche, MD, FIDSA, and Laura P. Hurley, MD, MPH, continue their discussion of the history, epidemiology, clinical burden, morbidity, and mortality of RSV in adults, particularly in vulnerable subgroups such as older adults or adults with cardiopulmonary conditions.

Are earlier age at menopause and hormone therapy linked to increased tau deposition? Find out about this and more in today's PV Roundup podcast.

Are earlier age at menopause and hormone therapy linked to increased tau deposition? Find out about this and more in today’s PV Roundup podcast.

Laura P. Hurley, MD, MPH, and Angela R. Branche, MD, FIDSA, discuss the history, epidemiology, clinical burden, morbidity, and mortality of RSV in adults, particularly in vulnerable subgroups such as older adults or adults with cardiopulmonary conditions.

Does Posttraumatic stress symptom severity predicts cognitive decline beyond the effect of Alzheimer's disease? Find out about this and more in today's PVRoundup podcast.